|
Congressional:
Senate Finance Committee Releases Draft Reconciliation Text
On Monday, the Senate Finance Committee released its portion of the reconciliation text covering the tax and health care portions of the bill. The bill keeps several Medicaid provisions that were in the House package, including increased eligibility checks for people in the Medicaid expansion population, work requirements of 80 hours per month, and limiting Affordable Care Act (ACA) premium tax credits and Special Enrollment Periods (SEPs).
Other provisions in the Senate bill went further than the House-passed version. Notably, the Senate version would institute stricter caps on provider taxes. The House-passed version of the bill included a provision that would have frozen provider taxes for two years, but the Senate version goes further by lowering a 6 percent cap on provider taxes by 0.5 percent annually in states that have expanded Medicaid until it reaches 3.5 percent in 2031. Senator Josh Hawley (R-MO) was critical of the provision, telling reporters Tuesday that he spoke with President Donald Trump about the bill and that the president was unaware of the changes to the provider taxes in the Senate version.
The Senate version also dropped several provisions in the health bill, including increasing Medicare payments to physicians or a “doc fix,” exempting more rare disease (orphan) drugs from Medicare drug price negotiations, Medicare pharmacy benefit manager (PBM) reforms, expanding the number of rural hospitals that can convert to a rural emergency hospital (REH) under the Medicare program, delaying the Medicaid Disproportionate Share Hospital (DSH) reductions, expanding the use of Health Savings Accounts (HSAs), and a provision codifying existing regulatory guidance on CHOICE Arrangements that allow employers to offer Individual Choice Health Reimbursement Arrangements (ICHRAs).
Following the release of the bill, Senate Minority Leader Chuck Schumer (D-NY) reiterated the party’s opposition to the healthcare provisions in the Senate bill, stating that the Democrats will continue to push back against the Republican-led provisions. Senate Majority Leader John Thune has said he wants to bring the package to the floor next week, allowing the House the opportunity to vote on final passage before July 4. On Friday, the Senate Finance Committee began its “Byrd Bath” process to litigate tax and health provisions with the Senate parliamentarian.
Read the text here, the section-by-section here, and Mehlman’s side-by-side comparison of the major provisions in each bill here.
Senate Confirms Gary Andres for Assistant HHS Secretary
On Tuesday, the Senate confirmed Gary Andres as Assistant Secretary of Health and Human Services in a 57-40 vote. Several Democrats voted with Republicans, including Senators Maggie Hassan (D-NH) and Jeanne Shaheen (D-NH), Raphael Warnock (D-GA), Peter Welch (D-VT), and Sheldon Whitehouse (D-RI). Andres was previously a congressional staffer serving as the Republican staff director of the House Budget Committee. He previously served in that capacity for the House Ways and Means and Energy and Commerce Committees. Andres also previously worked in the White House Office of Legislative Affairs under Presidents George H.W. Bush and George W. Bush.
Notable Bills Introduced:
Senate HELP Chair Cassidy, Ranking Member Sanders, Colleagues Reintroduce SUPPORT Act to Continue Effort to Address the Nation’s Opioid and Mental Health Crisis
On Wednesday, Senators Bill Cassidy, M.D. (R-LA), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, Bernie Sanders (I-VT), ranking member of the HELP Committee, Lisa Murkowski (R-AK), Tammy Baldwin (D-WI), Markwayne Mullin (R-OK), Maggie Hassan (D-NH), Tommy Tuberville (R-AL), and John Hickenlooper (D-CO) reintroduced the SUPPORT for Patients and Communities Reauthorization Act, which bolsters prevention, treatment, and recovery services for Americans with substance use disorders and mental illness. Originally signed into law by President Trump in 2018, the SUPPORT Act reauthorization expired on September 30, 2023. Read the press release here and the bill here.
Representatives Cleaver, Harshbarger Introduce Bipartisan Bill to Expand Paramedicine Services Nationwide
On Tuesday, Representatives Emanuel Cleaver, II (D-MO) and Diana Harshbarger (R-TN) introduced bipartisan legislation to strengthen and expand paramedicine services in rural communities across the country. The Community Paramedicine Act of 2025 (CPA) would expand the scope of rural health grants to include mobile integrated health and community paramedicine grantees, enabling Americans in rural communities to receive centralized, mobile, and preventative care through local paramedics, also known as Community Paramedicine. Read the press release here and the bill here.
Senator Peters, Colleagues Reintroduce Bipartisan Bill to Strengthen Critical Drug Supply Chains and Mitigate Shortages
Late last week, Senators Gary Peters (D-MI), Ranking Member of the Senate Homeland Security and Governmental Affairs Committee, Marsha Blackburn (R-TN), Tim Kaine (D-VA), and Ted Budd (R-NC) reintroduced the bipartisan Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act to help increase supply chain resiliency for critical generic drugs and their key ingredients by bolstering supply reserves and domestic production capacity through federal contracts. The RAPID Reserve Act would help reduce drug shortages, enhance preparedness, and mitigate national security threats from U.S. overreliance on China for critical medications and their key ingredients. Read the press release here and the bill here.
Executive Branch:
FDA Launches Vouchers for Drug Developers Supporting US National Interests
On Tuesday, the Food and Drug Administration (FDA) announced its Commissioner’s National Priority Voucher (CNPV) program, which aims to increase drug development in areas that the FDA deems to be in support of U.S. national interests. Under the program, drug developers would be eligible to receive a voucher granting them an expedited review of their product from approximately 10-12 months to 1-2 months if the FDA determines that it falls into at least one of four categories: (1) addressing a health crisis in the U.S., (2) delivering more innovative cures for the American people, (3) addressing unmet public health needs, (3) increasing domestic drug manufacturing as a national security issue. FDA Commissioner Martin Makary stated in the press release, "Using a common-sense approach, the national priority review program will allow companies to submit the lion's share of the drug application before a clinical trial is complete so that we can reduce inefficiencies. The ultimate goal is to bring more cures and meaningful treatments to the American public." Read the press release here.
Advisory Committee on Immunization Practices to Vote on Thimerosal-Containing Flu Vaccine Recommendations
On Wednesday, the Centers for Disease Control and Prevention (CDC) posted the agenda for next week’s Advisory Committee on Immunization Practices (ACIP) meeting. The meeting will be the first time the new panel meets following Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s removal of the previous 17 members earlier this month. The agenda notably contains a vote on “thimerosal-containing” flu vaccine recommendations. Kennedy has previously tied thimerosal, a mercury-containing preservative used in multidose vaccine vials, to autism, publishing a book in 2014 calling for the removal of thimerosal, despite several research studies rejecting the link. The panel is also no longer expected to vote on recommendations for COVID-19, HPV, and meningococcal vaccines, as had been outlined in a Federal Register notice earlier this month. See the agenda here.
Legal & Other:
Supreme Court Upholds Tennessee’s Ban on Gender-Affirming Care for Minors
On Wednesday, the Supreme Court upheld a Tennessee law that bans gender-affirming medical care for transgender minors in a 6-3 ruling. The court’s conservative majority concluded that the ban passed in 2023 does not discriminate against people based on their “transgender status.” The justices also rejected arguments from the law’s opponents that it amounts to unconstitutional discrimination on the basis of sex. Chief Justice John Roberts wrote in the majority opinion that “the voices in these debates raise sincere concerns; the implications for all are profound. The Equal Protection Clause does not resolve these disagreements. Nor does it afford us license to decide them as we see best.” Read the opinion here.
Federal Judge Orders HHS To Continue to Pay Infectious Disease Grants
On Tuesday, a federal judge blocked the Department of Health and Human Services (HHS) from terminating pandemic-era infectious disease grant funding to four local governments while a lawsuit against the department plays out. Columbus, Ohio; Kansas City, Missouri; Nashville, Tennessee; and Harris County, Texas have secured a preliminary injunction against the HHS after the department abruptly cut off COVID-19-era grant funding while still owing the municipalities payments. US District Court for the District of Columbia Judge Christopher R. Cooper wrote in his decision that “the Executive Branch does not have such broad power to refuse to spend appropriated funds.” Read the decision here.
Federal Judge Rules NIH Grant Terminations Unlawful
On Monday, a Massachusetts federal judge struck down directives by the National Institutes of Health (NIH) to cancel grants across the agency focusing on gender and diversity, equity, and inclusion. U.S. District Judge William Young ruled in two lawsuits that the directives were “arbitrary and capricious” and said they had “no force and effect.” Young’s order comes ahead of a full written opinion he intends to later write in the case, which will offer more details on his decision. The Department of Health and Human Services (HHS) is exploring legal options, including an appeal and a stay of the order. "HHS stands by its decision to end funding for research that prioritized ideological agendas over scientific rigor and meaningful outcomes for the American people," a department spokesperson said in a statement. "Under the leadership of Secretary Kennedy and the Trump administration, HHS is committed to ensuring that taxpayer dollars support programs rooted in evidence-based practices and gold standard science -- not driven by divisive DEI mandates or gender ideology." The cases are Am. Public Health Ass’n v. National Institutes of Health and Massachusetts v. Kennedy.
|